Saliva Test Identifies Healthy Older People with Cognitive Problems
By LabMedica International staff writers Posted on 15 Sep 2015 |
The saliva of healthy older people should be tested for the level of the stress hormone cortisol and this may help identify individuals who should be screened for problems with thinking skills.
The association between morning and evening salivary cortisol levels and regional brain volumes in older persons without dementia and the relationship with cognitive functioning to determine the potential clinical relevance of observed differences in brain volume has been investigated.
Scientists from the US National Institute on Aging (Bethesda, MD, USA) and their colleagues studied 4,244 persons without dementia whose mean age was 76 ± 5 years, and 58% were women. All enrollees had a brain magnetic resonance imaging (MRI) scan, and assessment of cognitive functioning. Saliva samples were taken from the participants once in the morning and in the evening to determine cortisol levels. Participants were divided into three groups based on cortisol levels of high, medium, and low.
Saliva samples were collected with the Salivette collection device (Sarstedt; Rommelsdorf, Germany). Salivary cortisol was analyzed with a Delfia time-resolved immunoassay with fluorescence detection (PerkinElmer; Waltham, MA, USA). The lower detection limit was 0.43 nmol/L for a 50-mL salivary sample. Morning or evening cortisol values of greater than 100 nmol/L were considered unreliable and excluded, but this was only 0.7% of morning samples and 0.5% of evening samples. Dementia ascertainment was a three-step protocol and a battery of six different cognitive tests was administered to all participants.
In the 4,244 participants, the mean morning cortisol level was 20 ±13.5 nmol/L and the median evening cortisol level was 2.3 nmol/L. People with the highest level of cortisol were more likely to have a smaller overall brain volume than those with lower levels of cortisol. Those with the highest level of cortisol also performed worse on the memory and thinking tests than those with low levels of the hormone. Poorer cognitive functioning across all domains was also associated with higher evening cortisol. Higher levels of morning cortisol were associated with slightly greater normal white matter volume and better processing speed and executive functioning, but not with gray matter volume or with memory performance.
Lenore J. Launer, PhD, the senior author of the study said, “Since this study just looked at a snapshot in time, we don’t know which came first: the high levels of cortisol or the loss of brain volume. It’s possible that the loss of brain volume that can occur with aging leads to a lesser ability of the brain to stop the effects of cortisol, which in turn leads to further loss of brain cells. Understanding these relationships may help us develop strategies to reduce the effects of cortisol on the brain and thinking skills.” The study was published on August 19, 2015, in the journal Neurology.
Related Links:
US National Institute on Aging
Sarstedt
PerkinElmer
The association between morning and evening salivary cortisol levels and regional brain volumes in older persons without dementia and the relationship with cognitive functioning to determine the potential clinical relevance of observed differences in brain volume has been investigated.
Scientists from the US National Institute on Aging (Bethesda, MD, USA) and their colleagues studied 4,244 persons without dementia whose mean age was 76 ± 5 years, and 58% were women. All enrollees had a brain magnetic resonance imaging (MRI) scan, and assessment of cognitive functioning. Saliva samples were taken from the participants once in the morning and in the evening to determine cortisol levels. Participants were divided into three groups based on cortisol levels of high, medium, and low.
Saliva samples were collected with the Salivette collection device (Sarstedt; Rommelsdorf, Germany). Salivary cortisol was analyzed with a Delfia time-resolved immunoassay with fluorescence detection (PerkinElmer; Waltham, MA, USA). The lower detection limit was 0.43 nmol/L for a 50-mL salivary sample. Morning or evening cortisol values of greater than 100 nmol/L were considered unreliable and excluded, but this was only 0.7% of morning samples and 0.5% of evening samples. Dementia ascertainment was a three-step protocol and a battery of six different cognitive tests was administered to all participants.
In the 4,244 participants, the mean morning cortisol level was 20 ±13.5 nmol/L and the median evening cortisol level was 2.3 nmol/L. People with the highest level of cortisol were more likely to have a smaller overall brain volume than those with lower levels of cortisol. Those with the highest level of cortisol also performed worse on the memory and thinking tests than those with low levels of the hormone. Poorer cognitive functioning across all domains was also associated with higher evening cortisol. Higher levels of morning cortisol were associated with slightly greater normal white matter volume and better processing speed and executive functioning, but not with gray matter volume or with memory performance.
Lenore J. Launer, PhD, the senior author of the study said, “Since this study just looked at a snapshot in time, we don’t know which came first: the high levels of cortisol or the loss of brain volume. It’s possible that the loss of brain volume that can occur with aging leads to a lesser ability of the brain to stop the effects of cortisol, which in turn leads to further loss of brain cells. Understanding these relationships may help us develop strategies to reduce the effects of cortisol on the brain and thinking skills.” The study was published on August 19, 2015, in the journal Neurology.
Related Links:
US National Institute on Aging
Sarstedt
PerkinElmer
Read the full article by registering today, it's FREE!
Register now for FREE to LabMedica.com and get complete access to news and events that shape the world of Clinical Laboratory Medicine.
- Free digital version edition of LabMedica International sent by email on regular basis
- Free print version of LabMedica International magazine (available only outside USA and Canada).
- Free and unlimited access to back issues of LabMedica International in digital format
- Free LabMedica International Newsletter sent every week containing the latest news
- Free breaking news sent via email
- Free access to Events Calendar
- Free access to LinkXpress new product services
- REGISTRATION IS FREE AND EASY!
Sign in: Registered website members
Sign in: Registered magazine subscribers
Latest Immunology News
- AI Predicts Tumor-Killing Cells with High Accuracy
- Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies
- AI Tool Precisely Matches Cancer Drugs to Patients Using Information from Each Tumor Cell
- Genetic Testing Combined With Personalized Drug Screening On Tumor Samples to Revolutionize Cancer Treatment
- Testing Method Could Help More Patients Receive Right Cancer Treatment
- Groundbreaking Test Monitors Radiation Therapy Toxicity in Cancer Patients
- State-Of-The Art Techniques to Investigate Immune Response in Deadly Strep A Infections
- Novel Immunoassays Enable Early Diagnosis of Antiphospholipid Syndrome
- New Test Could Predict Immunotherapy Success for Broader Range Of Cancers
- Simple Blood Protein Tests Predict CAR T Outcomes for Lymphoma Patients
- Cell Sorter Chip Technology to Pave Way for Immune Profiling at POC
- Chip Monitors Cancer Cells in Blood Samples to Assess Treatment Effectiveness
- Automated Immunohematology Approaches Can Resolve Transplant Incompatibility
- AI Leverages Tumor Genetics to Predict Patient Response to Chemotherapy
- World’s First Portable, Non-Invasive WBC Monitoring Device to Eliminate Need for Blood Draw
- Predictive T-Cell Test Detects Immune Response to Viruses Even Before Antibodies Form